Loading chart…
PRE-MARKET
Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. It offers formulations for anti-infectives, pain and analgesics, gastroenterology, rheumatology, respiratory, gynecology, and central nervous system, as well as for vitamins, minerals, and nutrition. The company also provides API products for antidiabetics, antidepressants, anti-histaminic, anaesthetic, anti-inflammatory, anti-coagulant, GERD, and gastric ulcer therapy, as well as antitussives and analgesics.
Wanbury Limited (WANBURY) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The WANBURY share price is ₹201.00 (+7.97% today), with a market capitalisation of ₹7B and a price-to-earnings (P/E) ratio of 12.3. MarketRipple tracks the WANBURY investment thesis, the ripple-chain impact of market events on Wanbury Limited, and the Healthcare sector outlook.
Open
₹200.00
High
₹204.40
Low
₹196.01
Prev. Close
₹186.16
52W High
₹358.85
52W Low
₹161.50
Day range
₹196.01–₹204.40
52-week range
₹161.50–₹358.85
Volume
99K
P/E
12.3
ROE
45.8%
D/E
1.55
Margin
8.6%
Wanbury Limited (NSE: WANBURY) is currently trading at ₹201.00 (+7.97%).
Wanbury Limited's market capitalization is ₹7B.
Wanbury Limited's price-to-earnings (P/E) ratio is 12.3.
Wanbury Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).